|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/5517 | (2013.01) | ||
| A61K 31/5517 | (2006.01) | ||
| A61K 9/08 | (2013.01) | ||
| A61P 21/02 | (2006.01) | ||
| C07D 487/04 | (2013.01) | ||
| A61P 23/00 | (2006.01) | ||
| A61K 9/19 | (2013.01) | ||
| A61P 25/08 | (2006.01) | ||
| A61P 21/02 | (2018.01) | ||
| A61P 25/20 | (2006.01) | ||
| A61P 23/00 | (2018.01) | ||
| A61P 25/22 | (2006.01) | ||
| A61P 25/08 | (2018.01) | ||
| A61K 9/08 | (2006.01) | ||
| A61P 25/22 | (2018.01) | ||
| A61K 9/19 | (2006.01) | ||
| A61P 25/20 | (2018.01) |
| (11) | Patento numeris | 3553059 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16923536.3 |
| Europos patento paraiškos padavimo data | 2016-12-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-10-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-10-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2016/109564 |
| Data | 2016-12-13 |
| (87) | Numeris | WO 2018/103119 |
| Data | 2018-06-14 |
| (30) | Numeris | Data | Šalis |
| 201611132114 | 2016-12-09 | CN |
| (72) |
HUANG, Haoxi , CN
ZHUO, Guoqing , CN
SHANG, Guoning , CN
LIANG, Zhen , CN
CHU, Ting , CN
CHEN, Cuicui , CN
LUO, Ming , CN
LI, Yingfu , CN
SU, Zhonghai , CN
|
| (73) |
Chengdu Brilliant Pharmaceutical Co., Ltd. ,
No. 3 attached to No.1
Jiuxing Avenue
HI-TECH Zone, Chengdu, Sichuan 610041,
CN
|
| (54) | 8-BROMO-1-METHYL-6-(2-PYRIDINYL)-4H-IMIDAZO[1,2-A][1,4]BENZODIAZEPINE-4-PROPANOIC ACID METHYL ESTER (REMIMAZOLAM, CNS 7056) HYDROBROMIDE (1:1) SALT FOR INJECTION FOR SEDATION AND ANESTHESIA |
| 8-BROMO-1-METHYL-6-(2-PYRIDINYL)-4H-IMIDAZO[1,2-A][1,4]BENZODIAZEPINE-4-PROPANOIC ACID METHYL ESTER (REMIMAZOLAM, CNS 7056) HYDROBROMIDE (1:1) SALT FOR INJECTION FOR SEDATION AND ANESTHESIA |